Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 4 | 2007 | 706 | 0.160 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2007 | 169 | 0.120 |
Why?
|
| HIV Infections | 3 | 2007 | 955 | 0.110 |
Why?
|
| Evolution, Molecular | 2 | 2006 | 349 | 0.100 |
Why?
|
| HLA-B Antigens | 2 | 2007 | 13 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 237 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2006 | 184 | 0.070 |
Why?
|
| Virus Replication | 2 | 2007 | 323 | 0.070 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2007 | 38 | 0.060 |
Why?
|
| Capsid | 1 | 2007 | 104 | 0.060 |
Why?
|
| Gene Products, env | 1 | 2006 | 18 | 0.060 |
Why?
|
| HIV Antigens | 1 | 2005 | 18 | 0.060 |
Why?
|
| HIV Seropositivity | 1 | 2006 | 81 | 0.060 |
Why?
|
| Point Mutation | 1 | 2006 | 168 | 0.060 |
Why?
|
| Selection, Genetic | 1 | 2005 | 90 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 198 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2006 | 675 | 0.050 |
Why?
|
| Mutation | 2 | 2007 | 2661 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 1589 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 1979 | 0.040 |
Why?
|
| Immunodominant Epitopes | 2 | 2007 | 59 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2005 | 2619 | 0.020 |
Why?
|
| Cyclophilin A | 1 | 2007 | 34 | 0.020 |
Why?
|
| Virion | 1 | 2007 | 122 | 0.020 |
Why?
|
| Viral Load | 1 | 2007 | 230 | 0.020 |
Why?
|
| HLA-B15 Antigen | 1 | 2005 | 1 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 92 | 0.010 |
Why?
|
| Drug Resistance, Viral | 1 | 2007 | 160 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2005 | 52 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 2005 | 26 | 0.010 |
Why?
|
| Germany | 1 | 2005 | 54 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 71 | 0.010 |
Why?
|
| AIDS Vaccines | 1 | 2005 | 72 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2006 | 170 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 491 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 300 | 0.010 |
Why?
|
| Epitopes | 1 | 2005 | 291 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2007 | 791 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 453 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2006 | 325 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 663 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2005 | 394 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 742 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2484 | 0.010 |
Why?
|
| Humans | 4 | 2007 | 65141 | 0.010 |
Why?
|
| United States | 1 | 2005 | 8098 | 0.010 |
Why?
|
| Adult | 1 | 2006 | 17358 | 0.000 |
Why?
|
| Male | 1 | 2006 | 31055 | 0.000 |
Why?
|
| Female | 1 | 2006 | 34030 | 0.000 |
Why?
|